BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11207826)

  • 1. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma.
    Robson A; Allen P; Hollowood K
    Histopathology; 2001 Feb; 38(2):135-40. PubMed ID: 11207826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma.
    Chorny JA; Barr RJ
    Am J Dermatopathol; 2002 Aug; 24(4):309-12. PubMed ID: 12142609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation.
    Trejo O; Reed JA; Prieto VG
    J Cutan Pathol; 2002 Aug; 29(7):397-406. PubMed ID: 12139634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
    Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
    J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX-10 staining in dermal scars.
    Behrens EL; Boothe W; D'Silva N; Walterscheid B; Watkins P; Tarbox M
    J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGFR (p75) expression in cutaneous scars; Further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma.
    Otaibi S; Jukic DM; Drogowski L; Bhawan J; Radfar A
    Am J Dermatopathol; 2011 Feb; 33(1):65-71. PubMed ID: 21178583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic differentiation of desmoplastic melanoma from cicatrices.
    Kaneishi NK; Cockerell CJ
    Am J Dermatopathol; 1998 Apr; 20(2):128-34. PubMed ID: 9557779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX10 expression in cutaneous scars: a potential diagnostic pitfall in the evaluation of melanoma re-excision specimens.
    Jackett LA; McCarthy SW; Scolyer RA
    Pathology; 2016 Oct; 48(6):626-8. PubMed ID: 27580960
    [No Abstract]   [Full Text] [Related]  

  • 9. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma.
    Kanik AB; Yaar M; Bhawan J
    J Cutan Pathol; 1996 Jun; 23(3):205-10. PubMed ID: 8793654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal Expression of SRY-related HMG-BOX Gene 10 (SOX-10) in Recent and Old Cutaneous Scars is a Potential Mimicker of Desmoplastic Malignant Melanoma.
    Febres-Aldana CA; Alexis J
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):197-204. PubMed ID: 30672775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cell histiocytosis mimicking malignant melanoma: a diagnostic pitfall.
    Billings TL; Barr R; Dyson S
    Am J Dermatopathol; 2008 Oct; 30(5):497-9. PubMed ID: 18806499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
    Sigal AC; Keenan M; Lazova R
    Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
    Orosz Z
    Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation.
    Huttenbach Y; Prieto VG; Reed JA
    J Cutan Pathol; 2002 Oct; 29(9):562-8. PubMed ID: 12358815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
    Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
    Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma.
    Lazova R; Tantcheva-Poor I; Sigal AC
    J Am Acad Dermatol; 2010 Nov; 63(5):852-8. PubMed ID: 20950740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
    Radfar A; Stefanato CM; Ghosn S; Bhawan J
    Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.
    Busam KJ; Iversen K; Coplan KC; Jungbluth AA
    Am J Surg Pathol; 2001 Feb; 25(2):197-204. PubMed ID: 11176068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.